Results 61 to 70 of about 10,363,664 (253)

Pharmacology

open access: yes, 2012
The history of pharmacology travels together to history of scientific method and the latest frontiers of pharmacology open a new world in the search of drugs.

core   +1 more source

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues [PDF]

open access: yes, 2023
This Special Issue, titled “Psychoactive Substances: Pharmacology and Toxicology”, aims to provide an up-to-date overview of the pharmacology, clinical information, and toxicology of psychotropics, as well as the effects associated with their
Stefania Chiappini   +3 more
core   +1 more source

Research progress on the application of multi-scale computational methods in the research and development of anti-tuberculosis infection drugs

open access: yesFrontiers in Pharmacology
Tuberculosis (TB), driven by Mycobacterium tuberculosis (Mtb), remains a leading cause of mortality from infectious disease worldwide.​ The global dissemination of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains—coupled with ...
Yajing Zhao   +5 more
doaj   +1 more source

Angelica Dahurica Regulated the Polarization of Macrophages and Accelerated Wound Healing in Diabetes: A Network Pharmacology Study and In Vivo Experimental Validation

open access: yesFrontiers in Pharmacology, 2021
Diabetic wounds exhibit retarded and partial healing processes. Therefore, patients are exposed to an elevated risk of infection. It has been verified that Angelica dahurica (Hoffm.) Benth. and Hook. f. ex Franch. and Sav (A.
Yonghui Hu   +8 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

Systems Pharmacology‐Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes

open access: yes, 2017
Massive cancer genomics data have facilitated the rapid revolution of a novel oncology drug discovery paradigm through targeting clinically relevant driver genes or mutations for the development of precision oncology.
Lin, P   +5 more
core   +1 more source

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review

open access: yesFrontiers in Pharmacology, 2020
Numerous studies have shown that berberine and its derivatives demonstrate important anti-tumor effects. However, the specific underlying mechanism remains unclear.
Chaohe Zhang   +9 more
doaj   +1 more source

Investigation of the Multi-Target Mechanism of Guanxin-Shutong Capsule in Cerebrovascular Diseases: A Systems Pharmacology and Experimental Assessment

open access: yesFrontiers in Pharmacology, 2021
Guanxin-Shutong capsule (GXSTC), a combination of Mongolian medicines and traditional herbs, has been clinically proven to be effective in treating cerebrovascular diseases (CBVDs).
Juanli Zhang   +12 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

From In Vitro Efficacy to Long‐Term HbA1c Response for GLP‐1R/GlucagonR Agonism Using the 4GI‐HbA1c Systems Model

open access: yesCPT: Pharmacometrics & Systems Pharmacology
For the treatment of Type 2 Diabetes, high efficacy approaches such as Glucagon‐like peptide 1 (GLP‐1)‐based therapies are recommended for glucose control. Prediction of the clinical outcome of these therapies on glucose and hemoglobin A1c (HbA1c), using
Rolien Bosch   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy